Archives
-
Esflurbiprofen and SERT–nNOS: A Fast-Onset Model
2026-09-21
The reference study identifies esflurbiprofen as a candidate fast-onset antidepressant by screening for compounds that disrupt the SERT–nNOS interaction in the dorsal raphe nucleus. Its integrated behavioral, neuroimaging, pharmacodynamic, and molecular results support a mechanism in which altered transporter signaling reduces autoreceptor-mediated inhibition and restores serotonergic output.
-
Cy3 Rabbit Anti-Goat IgG (H+L) Antibody Guide
2026-09-21
The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody provides fluorescent detection of goat IgG primary antibodies in ICC/IF, frozen and paraffin tissue staining, flow cytometry, and ELISA workflows. It should not be selected for non-goat primary antibodies, assumed cross-species reactivity, or used in live-cell applications without separate validation.
-
TRIM66 and Monogenic Olfactory Receptor Expression
2026-09-20
The reference study identifies TRIM66 as an epigenetic repressor that helps convert initially polygenic olfactory receptor transcription into stable monogenic expression in mature olfactory sensory neurons. Genetic loss of Trim66 disrupts receptor selection, olfactory information processing, and innate odor-guided behavior, linking enhancer repression to sensory function.
-
Ibrexafungerp: From pH Biology to Assay Design
2026-09-19
Ibrexafungerp and MK 3118 retain Candida activity under vaginally relevant acidic conditions. This article translates the pivotal pH study into practical susceptibility-testing, resistance-interpretation, and preclinical-model decisions.
-
PRINT: RNA-Mediated Insertion at Safe-Harbor Loci
2026-09-18
The reference study introduces PRINT, an RNA-only strategy that uses avian R2 retroelement proteins to synthesize and insert transgenes at a multicopy human safe-harbor locus. Its biochemical and cellular data indicate that target-primed reverse transcription can support efficient, junction-validated insertion without donor DNA, while also defining important constraints for delivery, transgene length, and genomic safety.
-
HyperScribe™ T7 Fluorescein RNA Labeling
2026-09-18
Fluorescein RNA labeling can extend the TaCRVP–SlCAT2 discovery into spatial and transcript-level assays. This guide explains how to use a T7-based labeling workflow, choose controls, and avoid confusing RNA localization with protein mechanism.
-
IMP and the Spatial Biology of RNA Modifications
2026-09-17
APEX-RNA-MS is redefining how translational researchers study RNA modifications in dynamic cellular structures. This article connects the mechanistic findings of Seo et al. with practical assay design, positioning IMP as a useful reference component for rigorous RNA and nucleotide analysis while clarifying the limits of current spatial workflows.
-
Ceftolozane-Tazobactam in Nosocomial Pneumonia
2026-09-17
The reference study explains how ceftolozane-tazobactam combines structural protection against AmpC-mediated hydrolysis with potent antipseudomonal activity. Its synthesis of molecular, susceptibility, pharmacokinetic-pharmacodynamic, and ASPECT-NP clinical evidence supports a focused role in nosocomial pneumonia, while also highlighting limits related to resistance mechanisms, geography, and post-hoc subgroup interpretation.
-
Pseudo-UTP: Designing Better Modified mRNA Assays
2026-09-16
Pseudo-UTP enables controlled mRNA synthesis with pseudouridine modification, but its value depends on how RNA quality, translation, and reverse-transcription assays are designed. This guide presents an evidence-based framework for distinguishing nucleotide effects from workflow artifacts in vaccine and gene therapy research.
-
SGC-CBP30 in LUAD Epigenetic Workflows
2026-09-16
SGC-CBP30 enables reversible testing of CREBBP/EP300 bromodomain dependence in super-enhancer and TGF-β/SMAD3 experiments. This guide translates findings from early-stage lung adenocarcinoma research into practical dose-response, chromatin, reporter, and troubleshooting workflows.
-
TRIM66 and Monogenic Olfactory Receptor Choice
2026-09-15
This study identifies TRIM66 as an epigenetic repressor that helps convert early, low-level expression of multiple olfactory receptor genes into the mature one-neuron-one-receptor state. Genetic loss of Trim66 disrupts receptor repression, neural activity, and innate olfactory behaviors, linking enhancer control to sensory function.
-
gamma-Glu-Cys: Designing Better Redox Assays
2026-09-15
Discover how gamma-Glu-Cys supports matrix-aware glutathione metabolism research, enzyme assays, and phytochelatin studies. This guide connects defined substrate selection with findings from Bacillus γ-glutamyl peptide research to improve experimental interpretation.
-
EZ Cap™ Firefly Luciferase mRNA (m1Ψ) Workflow
2026-09-14
Build a quantitative reporter workflow that separates mRNA delivery, translation, cell health, and signal kinetics. EZ Cap™ Firefly Luciferase mRNA (m1Ψ) also provides a practical benchmark for evaluating emerging transient-expression platforms, including the circular mRNA strategy reported in recent CAR-T research.
-
Protoporphyrin IX for Ferroptosis Workflows
2026-09-14
Build more interpretable photodynamic, heme-formation, and ferroptosis assays with Protoporphyrin IX. This workflow separates light-dependent activity from iron-handling biology and translates the METTL16-SENP3-LTF findings into practical experimental controls.
-
SAG in Frataxin-Deficient Astrocytes
2026-09-13
Vicente-Acosta and colleagues show that chronic Smoothened agonist treatment can reduce mitochondrial defects, reactive astrocyte features, and neuron toxicity caused by frataxin depletion. The study provides a mechanistic preclinical framework for examining Hedgehog pathway activation as a glia-focused strategy in Friedreich’s ataxia research.